Your Voice Your Vote 2024

Live results
Last Updated: April 23, 8:52:10PM ET

Clinical Trials Update: April 17, 2009

ByABC News
April 17, 2009, 5:08 PM

April 18 -- (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:

Restless Leg Syndrome (RLS)

This study seeks qualified participants with restless leg syndrome.

The research site is in DeLand, Fla.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/restless_legs.aspx.

-----

Depression

If you are 65 or older and have had symptoms of depression for at least four weeks, you may qualify for this study of an investigational medication.

The research site is in Cherry Hill, N.J.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.

-----

Rheumatoid Arthritis

If you have been diagnosed with rheumatoid arthritis and are not getting adequate relief from your current treatment regimen, you may qualify for this study of an investigational medication.

The research site is in San Antonio, Texas.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/arthritis.aspx.

-----

Healthy Patient Studies

If you are a healthy adult aged 18 to 55, you may qualify for this study.

The research site is in Neptune, N.J.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=361.

-----

Chronic Leg Pain

If you are aged 30 to 70, have moderate-to-severe chronic lower leg pain associated with lumbar disc herniation, and have had no improvement after conservative non-surgical treatment, you may qualify for this study.

The research site is in Detroit, Mich.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=304.

-----

Women's Health

If you are a postmenopausal woman aged 50 or older, you may qualify for this study.

The research site is in Missoula, Mont.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=438.